🟢 CervoMed is trading 5% up today on broad market strength

CervoMed is trading 5.24% up at $2.61, supported primarily by broad market strength.

• The S&P 500, Nasdaq Composite, and Dow Jones are all up more than 1% on September 11, 2026.
• CervoMed is participating in the Cantor Global Healthcare Conference at 10:55 a.m. ET.
• Its Phase 2a results were accepted for an October ISFTD presentation; no source explicitly attributes the intraday move to a company-specific catalyst, and the latest clinical announcement provided no numerical results.